A retrospective assessment of venous recanalization outcomes for oral anticoagulant treatment in deep vein thrombosis

Basit Öğe Kaydı
dc.contributor.authorGuzel, Anil
dc.contributor.authorCanbaz, Suat
dc.date.accessioned2024-06-12T11:17:03Z
dc.date.available2024-06-12T11:17:03Z
dc.date.issued2024
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective This study aims to provide effective treatment by comparing the venous recanalization responses of oral anticoagulants in deep vein thrombosis therapy.Methods From January 2013 to March 2019, a retrospective analysis was conducted on 109 patients who had been diagnosed with deep vein thrombosis and received treatment with apixaban, rivaroxaban, or warfarin within 1 week of symptom onset. Demographic, clinical data, and venous recanalization responses on Doppler ultrasonography of the patients that were followed-up 1 year from the date of diagnosis were evaluated.Results At the end of the 1-year follow-up, 21 (19.3%) patients had delayed recanalization, 39 (35.8%) patients had partial recanalization, and 49 (44.9%) patients had complete recanalization. The mean time to complete recanalization was 9.178 months for apixaban, 8.986 months for rivaroxaban, and 10.641 months for warfarin. Rivaroxaban was found to result in earlier completion of recanalization compared to warfarin (p = .012).Conclusion Direct oral anticoagulants might be more effective than vitamin K antagonists in achieving complete recanalization in patients that have deep vein thrombosis. Improving outcomes can be achieved by evaluating current treatment options.en_US
dc.identifier.doi10.1177/17085381241236931
dc.identifier.issn1708-5381
dc.identifier.issn1708-539X
dc.identifier.pmid38409653en_US
dc.identifier.scopus2-s2.0-85186611333en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1177/17085381241236931
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24563
dc.identifier.wosWOS:001173837000001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofVascularen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectVenous Thrombosisen_US
dc.subjectAnticoagulantsen_US
dc.subjectFactor Xa Inhibitorsen_US
dc.subjectRisken_US
dc.subjectAbnormalitiesen_US
dc.subjectFibrinolysisen_US
dc.subjectRivaroxabanen_US
dc.subjectPreventionen_US
dc.subjectRegressionen_US
dc.titleA retrospective assessment of venous recanalization outcomes for oral anticoagulant treatment in deep vein thrombosisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu